Logo 1 Logo 2

Clinical Trial Details

Trial ID: L7204
Source ID: NCT01680653
Associated Drug: Mini-Glucagon
Title: Testing State of the Art Remote Glucose Monitoring at Diabetes Camp
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01680653/results
Conditions: Type 1 Diabetes
Interventions: DRUG: Mini-glucagon|DEVICE: Remote monitoring|DIETARY_SUPPLEMENT: Carbohydrates
Outcome Measures: Primary: Duration of Nocturnal Hypoglycemia, Number of minutes with glucose reading \< 50 mg/dL. Each camper had Remote Monitoring nights and Control nights., 8 hours | Secondary: Duration of Glucose Readings <70 mg/dl, Number of minutes with glucose reading \< 70 mg/dL. Each camper had Remote Monitoring nights and Control nights., 8 Hours | Other: Prolonged Episodes of Hypoglycemic Events, Prolonged hypoglycemia is defined as glucose readings of either \<70 mg/dL for greater than one hour on and off the device, \<70 mg/dL for greater than 2 hours on and off the device, \<50 mg/dL that lasted longer than 30 minutes on and off the device and readings of \<50 mg/dL for longer than an hour, again for both the control and the subjects that were remotely monitored with the device. Each camper had Remote Monitoring nights and Control nights., 8 hours at night
Sponsor/Collaborators: Sponsor: Stanford University | Collaborators: University of Virginia|DexCom, Inc.|The Leona M. and Harry B. Helmsley Charitable Trust
Gender: ALL
Age: CHILD, ADULT
Phases:
Enrollment: 57
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Start Date: 2012-05
Completion Date: 2012-09
Results First Posted: 2018-03-05
Last Update Posted: 2018-03-05
Locations: Stanford University, Stanford, California, 94305, United States
URL: https://clinicaltrials.gov/show/NCT01680653